● Recruiting

Clinical Investigation of the Cardioprotective Effect of Early Administration of SGLT2 in Patients Presented With AMI

Condition: Myocardial Infarction · Sponsor: Mohammad Hussien Tantawy Soliman

PhaseNA

Planned participants80

Who can joinAll sexes, 18 Years to 80 Years

Healthy volunteersNo

About this study

This study aims to investigate the effect of early administration of DAPA during ischemia and before pPCI on infarct size, reperfusion injury-related myocardial damage, cardioprotection from HF, and renoprotection from AKI in patients with AMI.

This description comes directly from the study's public registry record.

Talk to the study team

Mohammad Soliman · +201003474565 · dr.mhtantawy@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Mohammad Soliman

Shibīn al Kawm, Menofia, Egypt

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06009874